Cargando…

Synthetic oligonucleotides as therapeutic agents.

Detalles Bibliográficos
Autor principal:	Tidd, D. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1991
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971642/ https://www.ncbi.nlm.nih.gov/pubmed/1989666

Ejemplares similares

Systematic Combination of Oligonucleotides and Synthetic Polymers for Advanced Therapeutic Applications
por: Han, Moohyun, et al.
Publicado: (2021)

Oligonucleotide Therapeutics
por: Stein, Cy A., et al.
Publicado: (2010)

Detection of autoimmune antibodies in localized scleroderma by synthetic oligonucleotide antigens
por: Samuelsen, Simone, et al.
Publicado: (2018)

Tandem mass spectrometric sequence characterization of synthetic thymidine‐rich oligonucleotides
por: Abdullah, A. M., et al.
Publicado: (2022)

Use of synthetic oligonucleotide probes to detect rhinovirus RNA
por: Bruce, Christine B., et al.
Publicado: (1989)

Coupling Strategies for the Synthesis of Peptide-Oligonucleotide Conjugates for Patterned Synthetic Biomineralization
por: Carter, Joshua D., et al.
Publicado: (2011)

Enhancing cardiac reprogramming via synthetic RNA oligonucleotides
por: Hu, Jiabiao, et al.
Publicado: (2020)

The delivery of therapeutic oligonucleotides
por: Juliano, Rudolph L.
Publicado: (2016)

Oligonucleotides-Based Therapeutics
por: Lebleu, Bernard
Publicado: (2021)

Specificity of oligonucleotide gene therapy (OGT) agents
por: Nedorezova, Daria D., et al.
Publicado: (2022)

Detection of enteroviruses using cDNA and synthetic oligonucleotide probes
por: Bruce, C., et al.
Publicado: (1989)

Trioleyl Pyridinium, a Cationic Transfection Agent for the Lipofection of Therapeutic Oligonucleotides into Mammalian Cells
por: Delgado, Ana, et al.
Publicado: (2023)

Delivery of therapeutic oligonucleotides in nanoscale
por: Wu, Lei, et al.
Publicado: (2021)

Characterization of self-assembled DNA concatemers from synthetic oligonucleotides
por: Sun, Lu, et al.
Publicado: (2014)

Oligonucleotide–Palladacycle Conjugates as Splice-Correcting Agents
por: Hande, Madhuri, et al.
Publicado: (2019)

Rational design of minimal synthetic promoters for plants
por: Cai, Yao-Min, et al.
Publicado: (2020)

Recent Advances in Oligonucleotide Therapeutics in Oncology
por: Xiong, Haoyu, et al.
Publicado: (2021)

Synthesis of Nucleobase-Modified RNA Oligonucleotides by Post-Synthetic Approach
por: Bartosik, Karolina, et al.
Publicado: (2020)

Synthetic oligonucleotides as quantitative PCR standards for quantifying microbial genes
por: Han, Xingguo, et al.
Publicado: (2023)

Bulge oligonucleotide as an inhibitory agent of bacterial topoisomerase I
por: Yang, Zhaoqi, et al.
Publicado: (2017)

Synthetic Oligonucleotides Inhibit CRISPR-Cpf1-Mediated Genome Editing
por: Li, Bin, et al.
Publicado: (2018)

Synthetic double-stranded RNA oligonucleotides are immunostimulatory for chicken spleen cells
por: Villanueva, A.I., et al.
Publicado: (2011)

Efficient electroporation of neuronal cells using synthetic oligonucleotides: identifying duplex RNA and antisense oligonucleotide activators of human frataxin expression
por: Shen, Xiulong, et al.
Publicado: (2019)

Investigating Synthetic Oligonucleotide Targeting of Mir31 in Duchenne Muscular Dystrophy
por: Hildyard, John CW, et al.
Publicado: (2016)

The role of chemistry in the success of oligonucleotides as therapeutics
por: Kumar, Pawan, et al.
Publicado: (2022)

Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic
por: Moreno, Pedro M. D., et al.
Publicado: (2014)

G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents
por: Musumeci, Domenica, et al.
Publicado: (2015)

Delivery of therapeutic oligonucleotides with cell penetrating peptides()
por: Boisguérin, Prisca, et al.
Publicado: (2015)

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
por: Hammond, Suzan M, et al.
Publicado: (2021)

Synthetic oligonucleotide antigens modified with locked nucleic acids detect disease specific antibodies
por: Samuelsen, Simone V., et al.
Publicado: (2016)

An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases
por: Fiszer, Agnieszka, et al.
Publicado: (2012)

Enzyme-Free Detection of Mutations in Cancer DNA Using Synthetic Oligonucleotide Probes and Fluorescence Microscopy
por: Miotke, Laura, et al.
Publicado: (2015)

Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides
por: Ghosh, Nilanjan, et al.
Publicado: (2018)

Therapeutic Potential of Tricyclo-DNA antisense oligonucleotides
por: Goyenvalle, Aurelie, et al.
Publicado: (2016)

Splice-switching antisense oligonucleotides as therapeutic drugs
por: Havens, Mallory A., et al.
Publicado: (2016)

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2020)

Sulfur modification in natural RNA and therapeutic oligonucleotides
por: Zheng, Ya Ying, et al.
Publicado: (2021)

Emerging Oligonucleotide Therapeutics for Rare Neuromuscular Diseases
por: Aoki, Yoshitsugu, et al.
Publicado: (2021)

Oligonucleotide Therapeutics: From Discovery and Development to Patentability
por: Moumné, Lara, et al.
Publicado: (2022)

Nonviral delivery systems for antisense oligonucleotide therapeutics
por: Huang, Si, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bpjpvjs9u734et8cobgskup6gr